Quarter
Charts

Scilex Holding Co

SCLX

CIK 0001820190 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$5M
↓-67.8% -$10Mvs FY2024 (Q4)
Gross Profit
$2M
↓-78.7% -$8Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
33/100
  • Profitability
    100ROIC 136.5% (10% = solid, 20%+ = moat)
  • Liquidity
    0Current Ratio 0.08 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.13x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -67.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin -1766.2% · trend -706.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project SCLX's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$5741.93
Total enterprise IV
$63M
Diluted shares
0.00B
Terminal PV
$46M (72% of total)
Year-5 FCF
$5M
YearProjected FCFDiscounted PV
+1$4M$4M
+2$4M$4M
+3$5M$3M
+4$5M$3M
+5$5M$3M
Terminal$74M$46M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$133K
investment in PP&E
Dividends paid (TTM)
—
cash returned to holders
Stock-based comp (TTM)
$15M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$365M
everything owned
Total liabilities
$577M
everything owed
Stockholders' equity
$-208M
shareholder claim
Net debt
$-5M
Net cash position ($5M)

Recent performance · 23 quarters

Revenue↓-67.8% -$10M
$5M
Net Income↓-5775.6% -$253M
$-258M
Free Cash Flow↓-105.2% -$3M
$-133K
Operating Margin↓-1628.2pts
-1766.2%

Drill down

SCLX Sankey

See Scilex Holding Co's revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

SCLX Charts

23 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

SCLX Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics